You might argue that the most attractive thing about EIS and VCT funds is the raft of tax benefits that accompany them. They certainly are generous – both are CGT-free and offer 30% income tax relief. But focus too much on the tax and you might miss one of their most rewarding and exciting aspects. … Continued
Madeleine Ingram, Head of Investor Relations at Calculus Capital looks at the pros and the cons of both venture capital trusts (VCTs) and enterprise investment schemes (EISs) for What Investment magazine. In the past 10 years the VCT and EIS markets have doubled in size as awareness of them has grown and the amount investors can save … Continued
One million parcels delivered. That’s the staggering figure shaving subscription service Cornerstone has achieved in just four and a half years, with more than 250,000 customers receiving its packages. Oliver Bridge, founder and Class of 2015 Young Gun, started the business from his kitchen table with a loan of just £5,000. It has since raised … Continued
Rule changes announced in last year’s budget will affect unwitting VCT investors. Here Calculus Capital CEO John Glencross highlights questions which advisers and investors should be asking providers. HMRC does not give generous tax breaks without a reason, and the benefits associated with VCTs are undoubtedly generous. Income tax relief at 30%, tax-free dividends and … Continued
Experienced industry CEO Jan Ward CBE is to chair the board of the Calculus Venture Capital Trust when current Chairman Michael O’Higgins steps down later this year. Ward has more than 30 years’ experience in the oil, gas, petrochemical and power industry. A mechanical engineer, she is founder and CEO of Corrotherm International Ltd, which … Continued
In Professional Adviser’s webinar ‘EIS under the bonnet’, three of the UK’s leading experts in the sector offer guidance on how advisers should grill prospective fund managers in their EIS due diligence. Calculus Capital chief executive John Glencross – who is joined on the panel by Par Equity LLP partner Paul Munn and The SidebySide … Continued
Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist Calculus Capital has invested £2.5m in fintech company Essentia Analytics, a leading provider of behavioural data analytics and consulting for professional investors. The investment by Calculus will be used to further develop Essentia’s services as it scales its client base of investment management institutions around … Continued
Brexit, Trump, trade wars and some unusually violent bouts of market volatility – what a year that was for investors. It was quite a year for the VCT and EIS industry too, with many managers forced by new legislation to change their whole business model. But, as we’ve said before, one of the advantages of … Continued
Successful offer to waive 3-5% initial frees extended to mid-February on request of advisers battling to beat tax return deadlines London, 18th Jan 2018: Award-winning Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist Calculus Capital has extended the zero initial fees offer on its new VCT until the middle of February. Calculus’s … Continued
Samantha Paston, PhD appointed Head of Research; Adrian Parry, PhD appointed Head of Manufacturing Appointments add significant expertise to further advance Scancell’s pipeline of cancer immunotherapies Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, today announces the appointment of Dr Samantha Paston as Head of Research and Dr Adrian Parry … Continued